What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease

por Targher, Giovanni
Publicado 2020

NAFLD: Is There Anything New under the Sun?

por Lonardo, Amedeo, Targher, Giovanni
Publicado 2017

Type 2 Diabetes and Dietary Carbohydrate Intake of Adolescents and Young Adults: What Is the Impact of Different Choices?

por Bonsembiante, Luisa, Targher, Giovanni, Maffeis, Claudio
Publicado 2021

Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure

por Inciardi, Riccardo M., Mantovani, Alessandro, Targher, Giovanni
Publicado 2023

Nonalcoholic fatty liver disease – a growing public health problem

por Mikolašević, Ivana, Filipec Kanižaj, Tajana, Targher, Giovanni
Publicado 2021

Iron and thrombosis

por Franchini, Massimo, Targher, Giovanni, Montagnana, Martina, Lippi, Giuseppe
Publicado 2007

Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?

por Mantovani, Alessandro, Gisondi, Paolo, Lonardo, Amedeo, Targher, Giovanni
Publicado 2016

NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management

por Lonardo, Amedeo, Mantovani, Alessandro, Lugari, Simonetta, Targher, Giovanni
Publicado 2019

Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum

por Tavaglione, Federica, Targher, Giovanni, Valenti, Luca, Romeo, Stefano
Publicado 2020

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications

por Lonardo, Amedeo, Mantovani, Alessandro, Targher, Giovanni, Baffy, Gyorgy
Publicado 2022

Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications

por Franchini, Massimo, Capra, Franco, Targher, Giovanni, Montagnana, Martina, Lippi, Giuseppe
Publicado 2007

The effect of iron depletion on chronic hepatitis C virus infection

por Franchini, Massimo, Targher, Giovanni, Capra, Franco, Montagnana, Martina, Lippi, Giuseppe
Publicado 2008

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies

por Mantovani, Alessandro, Byrne, Christopher D., Zheng, Ming-Hua, Targher, Giovanni
Publicado 2020

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials

por Mantovani, Alessandro, Petracca, Graziana, Csermely, Alessandro, Beatrice, Giorgia, Targher, Giovanni
Publicado 2020

Could Targeted Pharmacotherapies Exert a “Disease Modification Effect” in Patients with Chronic Plaque Psoriasis?

por Bellinato, Francesco, Chiricozzi, Andrea, Piaserico, Stefano, Targher, Giovanni, Gisondi, Paolo
Publicado 2022

Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis

por Maurelli, Martina, Gisondi, Paolo, Bellinato, Francesco, Mantovani, Alessandro, Targher, Giovanni, Girolomoni, Giampiero
Publicado 2023

Increased Pulse Pressure Independently Predicts Incident Atrial Fibrillation in Patients With Type 2 Diabetes

por Valbusa, Filippo, Bonapace, Stefano, Bertolini, Lorenzo, Zenari, Luciano, Arcaro, Guido, Targher, Giovanni
Publicado 2012

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight

por Ballestri, Stefano, Nascimbeni, Fabio, Romagnoli, Dante, Baldelli, Enrica, Targher, Giovanni, Lonardo, Amedeo
Publicado 2016

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Tria...

por Mantovani, Alessandro, Petracca, Graziana, Beatrice, Giorgia, Csermely, Alessandro, Lonardo, Amedeo, Targher, Giovanni
Publicado 2021

Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review

por Miao, Lei, Xu, Jing, Targher, Giovanni, Byrne, Christopher D, Zheng, Ming-Hua
Publicado 2022